DEK is a poly(ADP-ribose) acceptor in apoptosis and mediates resistance to genotoxic stress

被引:88
作者
Kappes, F. [1 ,2 ]
Fahrer, J. [1 ]
Khodadoust, M. S. [2 ,3 ]
Tabbert, A. [1 ]
Strasser, C. [1 ]
Mor-Vaknin, N. [2 ,3 ]
Moreno-Villanueva, M. [1 ]
Buerkle, A. [1 ]
Markovitz, D. M. [2 ,3 ,4 ]
Ferrando-May, E. [1 ]
机构
[1] Univ Konstanz, Dept Biol, D-78457 Constance, Germany
[2] Univ Michigan, Med Ctr, Dept Internal Med, Div Infect Dis, Ann Arbor, MI 48109 USA
[3] Univ Michigan, Med Ctr, Program Immunol, Ann Arbor, MI 48109 USA
[4] Univ Michigan, Med Ctr, Cellular & Mol Biol Program, Ann Arbor, MI 48109 USA
关键词
D O I
10.1128/MCB.01921-07
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
DEK is a nuclear phosphoprotein implicated in oncogenesis and autoimmunity and a major component of metazoan chromatin. The intracellular cues that control the binding of DEK to DNA and its pleiotropic functions in DNA- and RNA-dependent processes have remained mainly elusive so far. Our recent finding that the phosphorylation status of DEK is altered during death receptor-mediated apoptosis suggested a potential involvement of DEK in stress signaling. In this study, we show that in cells committed to die, a portion of the cellular DEK pool is extensively posttranslationally modified by phosphorylation and poly (ADP-ribosyl)ation. Through interference with DEK expression, we further show that DEK promotes the repair of DNA lesions and protects cells from genotoxic agents that typically trigger poly (ADP-ribose) polymerase activation. The posttranslational modification of DEK during apoptosis is accompanied by the removal of the protein from chromatin and its release into the extracellular space. Released modified DEK is recognized by autoantibodies present in the synovial fluids of patients affected by juvenile rheumatoid arthritis/juvenile idiopathic arthritis. These findings point to a crucial role of poly (ADP-ribosyl)ation in shaping DEK's autoantigenic properties and in its function as a promoter of cell survival.
引用
收藏
页码:3245 / 3257
页数:13
相关论文
共 67 条
[1]  
Ageberg M, 2006, HAEMATOL-HEMATOL J, V91, P268
[2]  
Alexiadis V, 2000, GENE DEV, V14, P1308
[3]   The extracellular release of HMGB1 during apoptotic cell death [J].
Bell, Charles W. ;
Jiang, Weiwen ;
Reich, Charles F., III ;
Pisetsky, David S. .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2006, 291 (06) :C1318-C1325
[4]   DAMPs, PAMPs and alarmins: all we need to know about danger [J].
Bianchi, Marco E. .
JOURNAL OF LEUKOCYTE BIOLOGY, 2007, 81 (01) :1-5
[5]   The SAF-box domain of chromatin protein DEK [J].
Böhm, F ;
Kappes, F ;
Scholten, I ;
Richter, N ;
Matsuo, H ;
Knippers, R ;
Waldmann, T .
NUCLEIC ACIDS RESEARCH, 2005, 33 (03) :1101-1110
[6]   Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion [J].
Bonaldi, T ;
Talamo, F ;
Scaffidi, P ;
Ferrera, D ;
Porto, A ;
Bachi, A ;
Rubartelli, A ;
Agresti, A ;
Bianchi, ME .
EMBO JOURNAL, 2003, 22 (20) :5551-5560
[7]   Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro [J].
Bowman, KJ ;
Newell, DR ;
Calvert, AH ;
Curtin, NJ .
BRITISH JOURNAL OF CANCER, 2001, 84 (01) :106-112
[8]   Poly(ADP-ribose) -: The most elaborate metabolite of NAD [J].
Bürkle, A .
FEBS JOURNAL, 2005, 272 (18) :4576-4589
[9]   Transcriptional activation by AP-2α is modulated by the oncogene DEK [J].
Campillos, M ;
García, MA ;
Valdivieso, F ;
Vázquez, J .
NUCLEIC ACIDS RESEARCH, 2003, 31 (05) :1571-1575
[10]   DEK expression is controlled by E2F and deregulated in diverse tumor types [J].
Carro, Maria Stella ;
Spiga, Fabio Mario ;
Quarto, Micaela ;
Di Ninni, Valentina ;
Volorio, Sara ;
Alcalay, Myriam ;
Muller, Heiko .
CELL CYCLE, 2006, 5 (11) :1202-1207